Three committees of the European Medicines Agency will meet at this event: the Pharmacovigilance Risk Assessment Committee, the Committee for Advanced Therapies and the Paediatric Committee.
This meeting allows the committees to discuss fundamental issues of common interest that go beyond product-specific assessment procedures.
Organiser: Federal Ministry of Health